Latest / Your Daily Dose / NEW PROBLEMS SURFACE WITH GLP-1 DRUGS

Transcript

NEW PROBLEMS SURFACE WITH GLP-1 DRUGS · Your Daily Dose

• 0:00
  Speaker 1: You know, some of the first studies are coming out
• 0:02
  Speaker 1: now about the GLP-1 preps that so many people are
• 0:08
  Speaker 1: using right now and losing weight. And it's intriguing. This
• 0:13
  Speaker 1: is the first one that really looked at two major
• 0:15
  Speaker 1: side effects that are showing up. So if you're on
• 0:18
  Speaker 1: one of those GLP-1s, there are ways to protect around this.
• 0:22
  Speaker 1: Let's take a look at that. That's what we're going
• 0:23
  Speaker 1: to talk about today. Stay tuned. Hi, and welcome to
• 0:27
  Speaker 1: Health Talk with Dr. Lin, your daily dose. The information
• 0:30
  Speaker 1: you hear on this show is informational. It's not meant
• 0:33
  Speaker 1: to diagnose or treat any disease. Any kind of complete
• 0:37
  Speaker 1: health conditions must be checked out and discussed with your
• 0:41
  Speaker 1: primary care physician. Get ready for the good news of
• 0:44
  Speaker 1: the day. God bless you folks. And here is Dr. Lent.
• 0:49
  Speaker 1: Our daily devotional today, October 21st, 2026, comes from the
• 0:55
  Speaker 1: book of Psalms, chapter 139. To live in my presence
• 0:58
  Speaker 1: consistently You must expose and expel your rebellious tendencies. When
• 1:04
  Speaker 1: something interferes with your plans or desires, you tend to
• 1:07
  Speaker 1: resent my interference. Try to become aware of each resentment,
• 1:11
  Speaker 1: however petty it may seem. Ask my spirit to increase
• 1:15
  Speaker 1: your awareness of resentful feelings. Bring them boldly into the
• 1:18
  Speaker 1: light of my presence so that I can free you
• 1:20
  Speaker 1: from them. The ultimate solution to rebellious tendencies is submission
• 1:24
  Speaker 1: to my authority over you. The best response to losses
• 1:28
  Speaker 1: or thwarted hopes His praise. The Lord gives and the
• 1:32
  Speaker 1: Lord takes away. Blessed be the name of the Lord.
• 1:36
  Speaker 1: Remember that all good things, your possessions, your family and friends,
• 1:39
  Speaker 1: your health and abilities, your time, are gifts from me.
• 1:43
  Speaker 1: Instead of feeling entitled to all those blessings, respond to
• 1:46
  Speaker 1: them with gratitude. Be prepared to let go of anything
• 1:49
  Speaker 1: I take from you, but never let go of my hand.
• 1:54
  Speaker 1: Stay tuned.... 727-916-4215 to reach me off air. The new
• 2:55
  Speaker 1: study presented at the 2026 European Academy of Dermatology compared
• 3:22
  Speaker 1: 575 GLP-1 users with 1,329 people who had type 2 diabetes, obesity,
• 3:29
  Speaker 1: or both, who had never taken the drugs. Researchers recruited
• 3:33
  Speaker 1: participants in France, the United States, Brazil, and Mexico. Nail
• 3:38
  Speaker 1: detachment and discoloration appear to be more common among people
• 3:41
  Speaker 1: in GLP-1 weight loss than diabetes drugs, a recent study found.
• 3:46
  Speaker 1: But its authors said that that shouldn't stop the patients
• 3:48
  Speaker 1: from taking them. The biggest gap was in nail detachment,
• 3:53
  Speaker 1: where the nail separates from the nail bed. 39% of
• 3:56
  Speaker 1: GLP-1 users reported this, compared with 9% of non-users. Nail
• 4:02
  Speaker 1: discoloration was reported by 46% of GLP-1 users and 17%
• 4:08
  Speaker 1: of nons. Overall, 66% of GLP-1 users reported at least
• 4:12
  Speaker 1: one nail problem, compared with 53% of those who had
• 4:16
  Speaker 1: not taken the drug. The study is the first controlled
• 4:19
  Speaker 1: study to examine GLP-1 and its potential effects on nail health.
• 4:24
  Speaker 1: It was a cross-sectional, meaning it examined participants at one
• 4:28
  Speaker 1: point in time and relied on symptoms participants reported rather
• 4:32
  Speaker 1: than observations. According to the researchers, weight loss alone did
• 4:38
  Speaker 1: not appear to explain differences in nails. After accounting for
• 4:42
  Speaker 1: skin conditions and nutritional deficiencies, Nail detachment and discoloration were
• 4:47
  Speaker 1: still about two to three times more common among GLP-1 users.
• 4:51
  Speaker 1: Study author Dr. Charles Taib of Necker University in Paris
• 4:57
  Speaker 1: cautioned against reading too much into the results. Some of
• 5:00
  Speaker 1: the associations weakened after those adjustments, he said, suggesting part
• 5:04
  Speaker 1: of what the study showed could be attributed to factors
• 5:07
  Speaker 1: other than GLP-1s. Not everything that happens during GLP-1 treatment
• 5:11
  Speaker 1: is necessarily caused by the treatment, he said. but the
• 5:14
  Speaker 1: association did not disappear. Our study cannot go further on
• 5:18
  Speaker 1: that without an explanation. Another caveat. About half the GLP-1
• 5:24
  Speaker 1: users said they had nail problems before they started the treatment.
• 5:27
  Speaker 1: Diabetes can affect a person's nails. Diabetes is linked to yellowed, thickening,
• 5:32
  Speaker 1: and misshapen nails, more fungal infections, buildup of debris, and
• 5:36
  Speaker 1: tiny spots of bleeding under the nails. These changes can
• 5:40
  Speaker 1: show up under magnification even when the nails look normal
• 5:43
  Speaker 1: to the naked eye. A companion study of the same
• 5:46
  Speaker 1: participants also presented at the conference found 50% of the
• 5:50
  Speaker 1: GLP-1 users, 34% of the non-users reported unusual hair loss.
• 5:56
  Speaker 1: The researchers said hair loss often occurred alongside scalp symptoms
• 6:00
  Speaker 1: in GLP-1 users, including itching, redness, or scaling, and suggested
• 6:04
  Speaker 1: that factors beyond weight loss could contribute to hair, scalp,
• 6:08
  Speaker 1: and nail changes. Scalp inflammation was the rule rather than
• 6:12
  Speaker 1: the exception with GLP-1 users. which clinicians do not currently
• 6:16
  Speaker 1: look for, which may be treatable. The findings should wear awareness,
• 6:20
  Speaker 1: not alarm, they said. These changes are frequent, usually benign,
• 6:25
  Speaker 1: and are not a reason to stop an effective treatment
• 6:27
  Speaker 1: on one's own. Anyone who notices hair shedding or itching
• 6:31
  Speaker 1: or red scalp or nail changes should mention that to
• 6:33
  Speaker 1: their doctor rather than discontinue therapy. If you notice changes
• 6:37
  Speaker 1: in your nails, such as swelling, drainage, pigment around the nail,
• 6:40
  Speaker 1: or experience some pain, bring it to your doctor's attention.
• 6:43
  Speaker 1: Telehealth patients, she said, need to be monitored by their
• 6:46
  Speaker 1: health care provider. You need to be examined, and they
• 6:49
  Speaker 1: need to see the changes in your body visibly. It
• 6:52
  Speaker 1: is a disservice to the patients to be prescribed medications
• 6:55
  Speaker 1: and renewals without a complete physical exam. Tabe and his
• 6:59
  Speaker 1: team plan to follow patients as they start taking GLP-1s
• 7:04
  Speaker 1: using standardized skin and nail exams and lab monitoring. Hope
• 7:07
  Speaker 1: to learn when the changes develop, why they occur, and
• 7:10
  Speaker 1: whether or not they can be reversed. The answer is yes,
• 7:16
  Speaker 1: they can. We can take a look at that. I'm
• 7:19
  Speaker 1: just throwing out one thing called NAD +. It can
• 7:22
  Speaker 1: do an amazing job of stabilizing most of those problems.
• 7:25
  Speaker 1: If you have issues like that, give us a call.
• 7:27
  Speaker 1: We'll help you set up a protocol, 727-916-4215. God bless you, folks.